<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Histiocytic and interdigitating dendritic cell <z:hpo ids='HP_0100242'>sarcomas</z:hpo> are rare <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> originating from bone marrow-derived myeloid stem cells </plain></SENT>
<SENT sid="1" pm="."><plain>Recent studies have shown evidence of cross-lineage <z:mpath ids='MPATH_85'>transdifferentiation</z:mpath> of B cells in follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> to histiocytic and dendritic cell <z:hpo ids='HP_0100242'>sarcomas</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we report the morphologic, molecular and cytogenetic analysis of seven cases of <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo>/small lymphocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="C1302547" disease_type="Neoplastic Process" abbrv="">CLL/SLL</z:e>) associated with histiocytic and dendritic cell <z:hpo ids='HP_0100242'>sarcomas</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> seven patients were elderly males (median age 71 years) </plain></SENT>
<SENT sid="4" pm="."><plain>The B-cell <z:hpo ids='HP_0002664'>neoplasms</z:hpo> preceded the development of the histiocytic and dendritic cell <z:hpo ids='HP_0100242'>sarcomas</z:hpo> in six of seven patients, and one patient had both <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> diagnosed at the same time </plain></SENT>
<SENT sid="5" pm="."><plain>The <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> included four interdigitating dendritic cell <z:hpo ids='HP_0100242'>sarcomas</z:hpo>: one Langerhans cell <z:hpo ids='HP_0100242'>sarcoma</z:hpo>, one histiocytic <z:hpo ids='HP_0100242'>sarcoma</z:hpo> and one immature <z:hpo ids='HP_0002664'>neoplasm</z:hpo> with evidence of histiocytic origin </plain></SENT>
<SENT sid="6" pm="."><plain>Laser-capture microdissection and PCR analysis showed identical clonal immunoglobulin gene rearrangements in the two phenotypically distinct components in <z:hpo ids='HP_0000001'>all</z:hpo> cases </plain></SENT>
<SENT sid="7" pm="."><plain>There was a preferential usage of IGHV4-39 by the V-D-J gene rearrangement </plain></SENT>
<SENT sid="8" pm="."><plain>By fluorescence in situ hybridization (FISH) analysis, two cases showed deletion 17p in both components, whereas four cases had <z:mpath ids='MPATH_458'>normal</z:mpath> cytogenetic findings by FISH in the <z:e sem="disease" ids="C1302547" disease_type="Neoplastic Process" abbrv="">CLL/SLL</z:e> cells, but acquired cytogenetic abnormalities in the corresponding histiocytic and dendritic <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Chromosome 17p abnormalities were the most common cytogenetic abnormality detected in the <z:hpo ids='HP_0100242'>sarcomas</z:hpo>, seen in five of six cases studied </plain></SENT>
<SENT sid="10" pm="."><plain>Compared with the <z:e sem="disease" ids="C1302547" disease_type="Neoplastic Process" abbrv="">CLL/SLL</z:e> cells, the histiocytic/dendritic cells were largely negative for PAX5, but showed strong expression of PU.1 and variable and weak expression of CEBPÎ² </plain></SENT>
<SENT sid="11" pm="."><plain>Our study provides evidence for <z:mpath ids='MPATH_85'>transdifferentiation</z:mpath> of <z:e sem="disease" ids="C1302547" disease_type="Neoplastic Process" abbrv="">CLL/SLL</z:e> B cells to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> of dendritic and less often histiocytic lineage, and suggests that secondary genetic events may play a role in this phenomenon </plain></SENT>
</text></document>